UK markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9594+0.0024 (+0.25%)
At close: 04:00PM EDT
0.9750 +0.02 (+1.63%)
After hours: 07:53PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
9,330
9,210
6,608
6,645
4,210
Selling general and administrative
12,407
11,311
7,999
10,620
7,224
Total operating expenses
21,737
20,521
14,607
17,265
11,434
Operating income or loss
-21,737
-20,521
-14,607
-17,265
-11,434
Total other income/expenses net
-117
-85
-3,221
25.648
29.299
Income before tax
-21,854
-20,606
-17,828
-17,240
-11,405
Income tax expense
0
0
0
0
-
Income from continuing operations
-21,854
-20,606
-17,828
-17,240
-11,405
Net income
-21,854
-20,606
-17,828
-17,240
-11,405
Net income available to common shareholders
-21,854
-20,606
-22,331
-17,240
-22,884
Basic EPS
-
-
-1.97
-2.03
-5.50
Diluted EPS
-
-
-1.97
-2.03
-5.50
Basic average shares
-
-
11,309
8,497
4,158
Diluted average shares
-
-
11,309
8,497
4,158
EBITDA
-
-20,498
-14,561
-17,213
-11,390